5th World Congress on Cardiovascular Medicine Pharmacology

The conference will cover Cardiovascular Drug Discovery and its Molecular Mechanisms, including Novel Targets in Hypertension and the use of Pharmacogenomics for personalized care. Management of Cardiac Arrhythmias and Heart Failure, alongside Emerging Antithrombotic Therapies and approaches to Myocardial Ischemia, will be discussed. The Role of Inflammation and Endothelial Dysfunction in cardiovascular diseases will be explored, as well as Drug Repurposing. Key principles of Pharmacokinetics and Pharmacodynamics in Cardiology and the importance of Endothelial Nitric Oxide will be highlighted. Management of Lipids and Cholesterol and Cardiovascular Risk Factors will be addressed, alongside Cardiovascular Drug Safety. Targeting the RAAS system and the use of Biomarkers will be covered. Considerations for Special Populations, the mechanisms of Cardio protective Agents, the role of the Gut Microbiome, and the applications of Personalized Medicine and Nanomedicine in cardiology will also be discussed.